LOAN vs TECH · P/E 12, rev $9.7M vs P/E 65, rev $1.22B
Manhattan Bridge Capital Inc (LOAN) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Manhattan Bridge Capital Inc (LOAN) is a reit - mortgage company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported LOAN revenue for 2024-12-31 was $9.7M. Net income was $5.6M. Revenue was down 1.1% from 2023-12-31 to 2024-12-31. LOAN currently screens at market cap $66.3M and trailing P/E 12.1.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
LOAN currently screens at market cap $66.3M and trailing P/E 12.1. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the LOAN and TECH stock pages for the full models.
Not investment advice.